CD274 and neoplasm: They identified that activation of GPER by G-1, in melanoma xenografts, induces a decrease in c-Myc levels, which results in decreased cell surface expression of programmed cell death ligand-1 (PD-L1) and increased cell surface levels of human leukocyte antigen (HLA), which together lead to improved immune recognition of melanoma tumor cells.